This House resolution recognizes children and families affected by neuroblastoma and supports clinicians and researchers working on the disease. It lists facts from the resolution: about 600 to 800 new U.S. cases a year; neuroblastoma makes up about 8–10% of childhood cancers and about 15% of childhood cancer deaths; about 90% of cases are diagnosed before age 5; the 5-year survival for high-risk neuroblastoma is given as about 63%. The resolution notes common treatments (chemotherapy, surgery, radiation, stem cell transplant, immunotherapy), mentions long-term health problems survivors may face, highlights newer therapies under investigation, and says childhood cancers often receive less research funding. It expresses support for designating September 3, 2026, as "Neuroblastoma Awareness Day."
The resolution is a statement of support and recognition. It encourages awareness of neuroblastoma and the work of clinicians and researchers. The text says increased awareness can help earlier diagnosis, better outcomes, and more investment in research. The resolution does not itself create new programs or change medical treatments.
No publicly available information.
Supporters want a dedicated day to recognize the resilience of children and families, to honor clinicians and researchers, and to draw attention to the need for continued research and better treatments for high-risk or relapsed neuroblastoma. The resolution cites that awareness can support earlier diagnosis and drive investment in research.
No publicly available information.